Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Autoimmune Skin Diseases Linked To Risk Of Adverse Pregnancy Outcomes
- Author:
- Doug Brunk
Publish date: December 1, 2023
News

Conditional recommendations rule in new SARD-associated interstitial lung disease guidelines
- Author:
- Doug Brunk
Publish date: November 27, 2023
News

Abatacept reduced rates of progression to RA, phase 2b trial finds
- Author:
- Doug Brunk
Publish date: November 22, 2023
News
Benralizumab proves noninferior to mepolizumab for rare vasculitis, EGPA
- Author:
- Doug Brunk
Publish date: November 20, 2023
News

TNF inhibitors may be OK for treating RA-associated interstitial lung disease
- Author:
- Doug Brunk
Publish date: November 15, 2023
News

Vasculitis confers higher risk for adverse pregnancy outcomes
- Author:
- Doug Brunk
Publish date: November 15, 2023
News
Sharps injuries are common among Mohs surgeons, survey finds
- Author:
- Doug Brunk
Publish date: November 14, 2023
News
Incipient ulceration may affect prognosis in primary melanoma
- Author:
- Doug Brunk
Publish date: November 14, 2023
News

Pregnancies with low anti-SSA/Ro autoantibody levels: Forgo fetal heart rhythm monitoring?
- Author:
- Doug Brunk
Publish date: November 13, 2023
News

AAD updates guidelines for managing AD with phototherapy and systemic therapies
- Author:
- Doug Brunk
Publish date: November 13, 2023
News
Specialty-trained pathologists more likely to make higher-grade diagnoses for melanocytic lesions
- Author:
- Doug Brunk
Publish date: November 10, 2023
News
Most patients with psoriasis not engaged in highly shared decision-making
- Author:
- Doug Brunk
Publish date: November 3, 2023
News
FDA approves second treatment for adults with hidradenitis suppurativa
- Author:
- Doug Brunk
Publish date: November 1, 2023
News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
- Author:
- Doug Brunk
Publish date: November 1, 2023
News

Novel hydrogel holds promise for skin regeneration
- Author:
- Doug Brunk
Publish date: October 31, 2023